TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $146,509 | -66.3% | 17,525 | 0.0% | 0.17% | -60.0% |
| Q2 2023 | $435,321 | +65.2% | 17,525 | 0.0% | 0.43% | +73.9% |
| Q1 2023 | $263,576 | +27.1% | 17,525 | 0.0% | 0.25% | +8.7% |
| Q4 2022 | $207,321 | +99.3% | 17,525 | 0.0% | 0.23% | +104.5% |
| Q3 2022 | $104,000 | +40.5% | 17,525 | 0.0% | 0.11% | +45.5% |
| Q2 2022 | $74,000 | -55.7% | 17,525 | 0.0% | 0.08% | -46.9% |
| Q1 2022 | $167,000 | -60.5% | 17,525 | -21.1% | 0.14% | -56.3% |
| Q4 2021 | $423,000 | -34.7% | 22,225 | 0.0% | 0.33% | -44.8% |
| Q3 2021 | $648,000 | – | 22,225 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |